PRF Technologies (PRFX) Payables (2019 - 2025)
PRF Technologies (PRFX) posted quarterly Payables of $213000.0 for Q4 2025, down 28.04% year-on-year from $296000.0 in Q4 2024, and little changed on a QoQ basis from $214000.0 in Q2 2025.
PRF Technologies (PRFX) Payables (2019 - 2025) Analysis & Trends
PRF Technologies (PRFX) has reported Payables for 7 consecutive years, with $213000.0 the latest figure, recorded in Q4 2025.
- Quarterly Payables fell 28.04% year-over-year to $213000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $213000.0 (down 28.04% YoY) and the FY2025 annual result came in at $213000.0, down 28.04% from the prior year.
- Payables was little changed at $213000.0 in Q4 2025 per PRFX's latest filing, from $214000.0 in the prior quarter.
- Over the last five years, Payables for PRFX reached as high as $385000.0 in Q3 2022 and fell as low as $57000.0 in Q2 2021.
- A 5-year average of $198823.5 and a median of $209000.0 in 2022 frame the typical range for Payables.
- Annual changes were most pronounced in 2021 — Payables tumbled 98.94% — and 2024, when it soared 328.99%.
- Year by year, Payables stood at $136000.0 in 2021, then jumped by 53.68% to $209000.0 in 2022, then tumbled by 66.99% to $69000.0 in 2023, then surged by 328.99% to $296000.0 in 2024, then dropped by 28.04% to $213000.0 in 2025.
- According to Business Quant data, Payables over the past three periods registered $213000.0, $214000.0, and $296000.0 for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 4.96 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.60 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 731.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 498.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 8.82 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.75 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 773.00 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 372.00 Mn |
| 10 | PRF Technologies | 745,168.93 | 451,168.93 | - | 213,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 213,000.00 |
| Jun 30, 2025 | 214,000.00 |
| Dec 31, 2024 | 296,000.00 |
| Jun 30, 2024 | 119,000.00 |
| Mar 31, 2024 | 209,000.00 |
| Dec 31, 2023 | 69,000.00 |
| Sep 30, 2023 | 214,000.00 |
| Jun 30, 2023 | 70,000.00 |
| Mar 31, 2023 | 313,000.00 |
| Dec 31, 2022 | 209,000.00 |
| Sep 30, 2022 | 385,000.00 |
| Jun 30, 2022 | 212,000.00 |
| Mar 31, 2022 | 334,000.00 |
| Dec 31, 2021 | 136,000.00 |
| Sep 30, 2021 | 171,000.00 |
| Jun 30, 2021 | 57,000.00 |
| Mar 31, 2021 | 159,000.00 |
| Dec 31, 2020 | 720,000.00 |
| Jun 30, 2020 | 5.36 Mn |
| Dec 31, 2019 | 5.31 Mn |